Therapeutic drug monitoring in developing nations: Assessing the current state of affairs in South America | ||
| dc.conicet.organizacion | Universidade Feevale | |
| dc.conicet.organizacion | Universidade Feevale | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan" | |
| dc.contributor.author | Venzon Antunes, Marina | |
| dc.contributor.author | Linden, Rafael | |
| dc.contributor.author | Schaiquevich, Paula Susana | |
| dc.date.issued | 2021-01 | |
| dc.description.abstract | Therapeutic drug monitoring (TDM) aims to offer assistance to clinicians to improve drug dosing and clinical outcomes, while minimizing the probability of serious adverse effects in routine clinical practice. Disease conditions, drug-drug and drug-herbal interactions, noncompliance, and genetic features affect the relationship between drug concentrations in the body and clinical effects. They contribute to the pharmacokinetic inter-patient variability which ultimately impactsdrug response, resulting in some patients showing lack of therapeutic effects while others experience toxicity. Thus, the identification of the sources of pharmacokinetic variability contributes to the adequacy of the dosing regimen [1]. However, performing TDM in Developing Nations as South American Countries is particularly challenging, mainly due to the lack of structure and economic aspects. | es |
| dc.description.fil | Fil: Venzon Antunes, Marina. Universidade Feevale; Brasil | |
| dc.description.fil | Fil: Linden, Rafael. Universidade Feevale; Brasil | |
| dc.description.fil | Fil: Schaiquevich, Paula Susana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Venzon Antunes, Marina; Linden, Rafael; Schaiquevich, Paula Susana; Therapeutic drug monitoring in developing nations: Assessing the current state of affairs in South America; Taylor & Francis; Expert Opinion on Drug Metabolism & Toxicology; 17; 3; 1-2021; 251-254 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1742-5255 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/163919 | |
| dc.journal.ciudad | London | es |
| dc.journal.number | 3 | es |
| dc.journal.pagination | 251-254 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Expert Opinion on Drug Metabolism & Toxicology | es |
| dc.journal.volume | 17 | es |
| dc.language.iso | eng | es |
| dc.publisher | Taylor & Francis | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/17425255.2021.1859478 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1859478 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | DEVELOPING NATION | es |
| dc.subject | PHARMACOGENETIC | es |
| dc.subject | SOUTH AMERICA | es |
| dc.subject | THERAPEUTIC DRUG MONITORING | es |
| dc.subject.classification | Otras Medicina Clínica | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Therapeutic drug monitoring in developing nations: Assessing the current state of affairs in South America | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.5c27735a-da92-448a-9d65-3f4fbf145957_B.pdf
- Tamaño:
- 736.66 KB
- Formato:
- Adobe Portable Document Format